Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Scandinavian ChemoTech AB (publ)
  6. News
  7. Summary
    CMOTEC B   SE0009242654

SCANDINAVIAN CHEMOTECH AB (PUBL)

(CMOTEC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Scandinavian ChemoTech : enters into an agreement with Erik Penser Bank to monitor the company in the form of assignment analyses

01/05/2021 | 07:46am EDT

Scandinavian ChemoTech AB (publ) has entered into an agreement with Erik Penser Bank AB to receive the service, Penser Access, where written analysis reports are the central part of the service.

The purpose of the agreement is to carry out a number of analyses that will aim to increase the stock market's knowledge of the company and provide indications of target prices.

"It feels good that ChemoTech is now deepening its collaboration with Erik Penser Bank and will be giving the stock market access to analyses and descriptions of the company's potential, developed by well-experienced analysts." - says Mohan Frick, CEO

For further information please contact: Mohan Frick, CEO

+46 (0)10-218 93 00

info@chemotech.se
 

Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail: info@penser.se

Scandinavian ChemoTech AB (publ)
ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer patients access to a new treatment alternative, tumour specific electroporation, available for treatment of both for humans and animals. There are a large number of cancer patients whose tumours for various reasons cannot be treated by conventional methods but where tumour specific electroporation can be a solution. Therefore, the company continuously evaluates new opportunities and areas of application for the technology. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Erik Penser Bank is the company's Certified Adviser. Read more at: www.chemotech.se.

https://news.cision.com/chemotech/r/scandinavian-chemotech-enters-into-an-agreement-with-erik-penser-bank-to-monitor-the-company-in-the-,c3264365

https://mb.cision.com/Main/14967/3264365/1356331.pdf

(c) 2021 Cision. All rights reserved., source Press Releases - English

All news about SCANDINAVIAN CHEMOTECH AB (PUBL)
09/06SCANDINAVIAN CHEMOTECH AB : is carrying out another directed new share issue and will rece..
AQ
09/03SCANDINAVIAN CHEMOTECH : subsidiary Vetiqure AB begins its marketing in the US
AQ
09/03SCANDINAVIAN CHEMOTECH : is carrying out a directed new share issue and will receive appro..
AQ
08/25SCANDINAVIAN CHEMOTECH AB : (publ) Interim report Q1 January - June 2021 - Executive Summa..
AQ
08/17Scandinavian Chemotech AB Publ Reports Earnings Results for the Second Quarter Ended Ju..
CI
07/16SCANDINAVIAN CHEMOTECH : Board member buys additional shares in Scandinavian ChemoTech AB
AQ
07/08SCANDINAVIAN CHEMOTECH : starts a feasibility study ináthe USA
AQ
07/08Scandinavian ChemoTech Starts Feasibility Study in the USA
CI
06/17SCANDINAVIAN CHEMOTECH : receives approval from the European Patent Office
AQ
06/17Scandinavian ChemoTech Receives Approval from the European Patent Office
CI
More news
Financials
Sales 2021 - - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 188 M 21,8 M 21,8 M
Capi. / Sales 2021 -
Capi. / Sales 2022 40,0x
Nbr of Employees 7
Free-Float 56,5%
Chart SCANDINAVIAN CHEMOTECH AB (PUBL)
Duration : Period :
Scandinavian ChemoTech AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 21,80 SEK
Average target price 21,50 SEK
Spread / Average Target -1,38%
Managers and Directors
Stefan Mohan Frick Chief Executive Officer & Director
Lars Olof Hedbys Chairman
Urban Hňkan WidÚn Chief Operating Officer
Bengt Georg Gustaf Engstr÷m Director
Rolf Bertil Ehrnstr÷m Director
Sector and Competitors